The Study of Trilaciclib Combined With Chemotherapy On The Neoadjuvant Therapy of TNBC
Status: NOT_YET_RECRUITING
Study type: INTERVENTIONAL
Conditions: Breast Neoplasm
Interventions: DRUG: Trilaciclib plus chemotherapy|DRUG: Chemotherapy
Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University